Search

Nearly 600 students from 12 schools in Barcelona city, L'Hospitalet de Llobregat, Montgat and Esplugues de Llobregat met during the month of May at Cibernàrium 22@ in Barcelona for the STEAM

Orphan Drug Designation is a special status granted by the FDA to drugs that are intended to treat rare diseases or conditions.

The reference forum of the biotechnology and life sciences industry in the European Atlantic Area celebrates its second edition in Vigo on June 12-13.

The final results of ATL-001, the biotech company's lead candidate, have shown that it is able to stabilize UROIIIS and recover its enzymatic activity.

The consulting firm specialized in the health sector will compare different quantitative data between patients suffering from these two types of infections in Spain.

The applied research and technological development center, TECNALIA , develops cutting-edge technologies that optimize processes in the agri-food sector.

Immunostep introduces an innovative reagent for CAR T cell detection, enhancing precision and efficiency in cancer immunotherapy.

These studies explore the use of advanced radiomics techniques and artificial intelligence-based analysis for the prediction of responses to oncology therapies and mutational status in lung cancer.

With this agreement, the FTH takes a fine step forward in its commitment to improve people's health and quality of life.

it is a medicine to improve progression-free survival and overall survival in patients with metastatic pancreatic adenocarcinoma.

Ownmed Innovation's technology provides an alternative to ostomy bags, allowing patients to have greater autonomy and control over waste disposal and improving their quality of life. The closure of

Meet KeyZell, our new member. We talked to its José del Corral, CEO.

The Spanish Agency for Medicines and Health Products (AEMPS) has certified compliance with the European Union Good Manufacturing Practices (GMP).

BIOLAN Microbiosensores, a world leader in biosensor technology applied to the food sector, has just launched its new development for the quantification of the SALT BIOFISH 7000 SALT is a unique

Dr. Manuel Hidalgo is working with Peaches Biotech in the development of a new treatment called opT cells, born from a collaborative project with Harvard Medical School.

ApTOLL shows potential for slowing the progression of multiple sclerosis (MS) in preclinical animal studies.